Diality, an Irvine, CA-based medical device company that is developing a versatile hemodialysis system to address the unmet technology needs of the evolving dialysis industry, closed a $12.5m Series B funding.
Backers were not disclosed.
The company intends to use the funds for all activities related to submitting to the US Food and Drug Administration for 510(k) clearance.
Led by Osman Khawar, M.D., Chief Executive Officer, Diality is a medical device company developing a versatile, portable hemodialysis machine. Committed to improving the quality of life of patients with kidney disease, the company is focusing on reducing patient burden of care and burnout and improving patient quality of life, as well as giving physicians the flexibility to prescribe personalized dialysis treatments regardless of delivery setting.